|
1.Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007; 57: 43-66. 2.GOLD P, FREEDMAN SO. Demonstration of tumor-specific antigen in human colonic carcinoma by immunological tolerance and absor- ption techniques. J Exp Med 1965; 121:439–462. 3.Fletcher RH. Carcinoembryonic antigen. Ann Intern Med 1986; 104: 66. 4.Cutait R, Alves VA, Lopes LC, Cutait DE, Borges JL, Singer J, da Silva JH, Goffi FS. Restaging of colorectal cancer based on the identification of lymph node micrometastases hrough immunoperoxidase staining of CEA and cytokeratins. Dis Colon Rectum 1991; 34(10):917–920. 5.Miller JR, Hocking AM, Brown JD, Moon RT. Mechanism and function of signal transduction by the Wnt/beta-catenin and Wnt/Ca2+ pathways. Oncogene 1999; 18: 7860-7872. 6.Polakis P. Wnt signaling and cancer. Genes Dev 2000; 14: 1837-1851. 7.Giles RH, van Es JH, Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 2003; 1653: 1-24. 8.Taipale J, Beachy PA. The Hedgehog and Wnt signaling pathways in cancer. Nature 2001; 411: 349-354. 9.Bienz M, Clevers H. Linking colorectal cancer to Wnt signaling. Cell 2000; 103: 311-320. 10.Wong NA, Pignatelli M. Beta-catenin--a linchpin in colorectal car- cinogenesis? Am J Pathol 2002; 160: 389-401. 11.Brabletz T, Herrmann K, Jung A, Faller G, Kirchner T. Expression of nuclear beta-catenin and c-myc is correlated with tumor size but not with proliferative activity of colorectal adenomas. Am J Pathol 2000; 156: 865-870. 12.Kirchner T, Brabletz T. Patterning and nuclear beta-catenin ex- pression in the colonic adenoma-carcinoma sequence. Analogies with embryonic gastrulation. Am J Pathol 2000; 157:1113-1121. 13.Brabletz T, Jung A, Hermann K, Gunther K, Hohenberger W, Kirchner T. Nuclear overexpression of the oncoprotein betacatenin in colorectal cancer is localized predominantly at the invasion front. Pathol Res Pract 1998; 194: 701-704. 14.Castellone MD, Teramoto H, Williams BO, Druey KM, Gutkind JS. Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. Science 2005; 310: 1504-1510. 15.Yang L, Lin C, Liu ZR. P68 RNA helicase mediates PDGF induced epithelial mesenchymal transition by displacing Axin from beta- catenin. Cell 2006; 127: 139-155. 16.Gupta GP, Massague J. Cancer metastasis: building a framework. Cell 2006; 127: 679-695. 17.Hollenbach AD, Sublett JE, McPherson CJ, Grosveld G. The Pax3- FKHR oncoprotein is unresponsive to the Pax3-associated repressor hDaxx. EMBO J 1999; 18:3702–3711. 18.Kiriakidou M, Driscoll DA, Lopez-Guisa JM, Strauss JF 3rd. Cloning and expression of primate Daxx cDNAs and mapping of the human gene to chromosome 6p21.3 in the MHC region. DNA Cell Biol 1997; 16:1289–1298. 19.Li H, Leo C, Zhu J, Wu X, O''Neil J, Park EJ, Chen JD. Sequestration and inhibition of Daxx-mediated transcriptional repression by PML. Mol Cell Biol 2000; 20:1784–1796. 20.Pluta AF, Earnshaw WC, Goldberg IG. Interphase-specific association of intrinsic centromere protein CENP-C with HDaxx, a death domain- binding protein implicated in Fas-mediated cell death. J Cell Sci 1998; 111 (14):2029-2041. 21.Cermák L, Símová S, Pintzas A, Horejsí V, Andera L. Molecular mechanisms involved in CD43-mediated apoptosis of TF-1 cells: roles of transcription, Daxx expression and adhesion molecules. J Biol Chem 2002; 277:7955–7961. 22.Perlman R, Schiemann WP, Brooks MW, Lodish HF, Weinberg RA. TGF-beta-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation. Nat. Cell Biol 2001; 3: 708–714. 23.Torii S, Egan DA, Evans RA, Reed JC. Daxx regulates Fas induced apoptosis from nuclear PML oncogenic domains (PODs). EMBO J 1999; 18:6037–6049. 24.Yang X, Khosravi-Far R, Chang HY, Baltimore D. Daxx, a novel Fas- binding protein that activates JNK and apoptosis. Cell 1997; 89: 1067– 1076. 25.Li R, Pei H, Watson DK, Papas TS. EAP1/Daxx interacts with ETS1 and represses transcriptional activation of ETS1 target genes. Oncogene 2000; 19:745–753. 26.Ohiro Y, Usheva A, Kobayashi S, Duffy SL, Nantz R, Gius D, Horikoshi N. Inhibition of stress-inducible kinase pathways by tumorigenic mutant p53. Mol Cell Biol 2003; 23:322–334. 27.Charette SJ, Lavoie JN, Lambert H, Landry J. Inhibition of Daxx- mediated apoptosis by heat shock protein 27. Mol Cell Biol 2000; 20: 7602– 7612. 28.Hofmann H, Sindre H, Stamminger T. Functional interaction betw- een the pp71 protein of human cytomegalovirus and the PML-i nteracting protein human Daxx. J Virol 2002; 76:5769–5783. 29.Li XD, Mäkelä TP, Guo D, Soliymani R, Koistinen V, Vapalahti O, Vaheri A, Lankinen H. Hantavirus nucleocapsid protein interacts with the Fas-mediated apoptosis enhancer Daxx. J Gen Virol 2002; 83: 759 –766. 30.Lin DY, Shih HM. Essential role of the 58-kDa microspherule protein in the modulation of Daxx-dependent transcriptional repression as revealed by nucleolar sequestration. J Biol Chem 2002; 277:25446 – 25456. 31.Ryu SW, Chae SK, Kim E. Interaction of Daxx, a Fas binding protein, with sentrin and Ubc9. Biochem. Biophys Res Commun 2000; 279: 6–10. 32.Florin L, Schäfer F, Sotlar K, Streeck RE, Sapp M. Reorganization of nuclear domain 10 induced by papillomavirus capsid protein l2. Virology 2002; 295:97–107. 33.Chang HY, Nishitoh H, Yang X, Ichijo H, Baltimore D. Activation of apoptosis signal- regulating kinase 1 (ASK1) by the adapter protein daxx. Science 1998; 281:1860–1863. 34.Kadosh D, Struhl K. Repression by Ume6 involves recruitment of a complex containing sin3 corepressor and Rpd3 Histone deacetylase to target promoters. Cell 1997; 89:365–371. 35.Ko YG, Kang YS, Park H, Seol W, Kim J, Kim T, Park HS, Choi EJ, Kim S. Apoptosis signal-regulating kinase 1 controls the proapoptotic func -tion of death-associated protein (Daxx) in the cytoplasm. J Biol Chem 2001; 276:39103–39106. 36.Green DR. Apoptotic pathways: paper wraps stone blunts scissors. Cell 2000; 102:1–4. 37.Hengartner MO. The biochemistry of apoptosis. Nature 2000; 407: 770–776. 38.Shi Y. Mechanisms of caspase activation and inhibition during apop- tosis. Mol. Cell 2002; 9:459–470. 39.Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenor- habditis elegans. Nature 1998; 391:806–811. 40.Genini D, Sheeter D, Rought S, Zaunders JJ, Susin SA, Kroemer G, Richman DD, Carson DA, Corbeil J, Leoni LM. HIV induces lymphocyte apoptosis by a p53-initiated, mitochondrial-mediated mechanism. FASEB J 2001; 15:5–6. 41.Suzuki T, Kiyokawa N, Taguchi T, Sekino T, Katagiri YU, Fujimoto J. CD24 induces apoptosis in human B cells via the glycolipid-enriched membrane domains/rafts-mediated signaling system. J Immunol 2001; 166:5567–5577. 42.Kadmon G, von Bohlen und Halbach F, Schachner M, Altevogt P. Differential, LFA-1-sensitive effects of antibodies to nectadrin, the heat-stable antigen, on B lymphoblast aggregation and signal trans- duction. Biochem Biophys Res Commun 1994; 198: 1209–1215. 43.Sammar M, Gulbins E, Hilbert K, Lang F, Altevogt P. Mouse CD24 as a signaling molecule for integrin-mediated cell binding: functional and physical association with src-kinases. Biochem Biophys Res Commun. 1997; 234:330–334. 44.Kadmon G, Eckert M, Sammar M, Schachner M, Altevogt P. Nect -adrin, the heat-stable antigen, is a cell adhesion molecule. J Cell Biol 1992; 118:1245–1258. 45.Poncet C, Frances V, Gristina R, Scheiner C, Pellissier JF, Figarella- Branger D. CD24, a glycosylphosphatidylinositolanchored molecules is transiently expressed during the development of human central nervous system and is a marker of human neural cell lineage tumors. Acta Neuropathol 1996; 91:400–408. 46.Cram DS, McIntosh A, Oxbrow L, Johnston AM, DeAizpurua HJ. Differential mRNA display analysis of two related but functionally distinct rat insulinoma (RIN) cell lines: identification of CD24 and its expression in the developing pancreas. Differentiation 1999; 64: 237–246. 47.Shirasawa T, Akashi T, Sakamoto K, Takahashi H, Maruyama N, Hirokawa K. Gene expression of CD24 core peptide molecule in developing brain and developing non-neural tissues. Dev Dyn 1993; 198:1–13. 48.Figarella-Branger D, Moreau H, Pellissier JF, Bianco N, Rougon G. CD24, a signal-transducing molecule expressed on human B lympho -cytes, is a marker for human regenerating muscle. Acta Neuro- pathol 1993; 86:275–284. 49.Redondo P, García-Foncillas J, Okroujnov I, de Felipe I, Quintanilla E. CD24 expression on human keratinocytes. Exp Dermatol 1998; 7: 175–178. 50.Baumann P, Cremers N, Kroese F, Orend G, Chiquet-Ehrismann R, Uede T, Yagita H, Sleeman JP. CD24 expression causes the acquisition of multiple cellular properties associated with tumor growth and metastasis. Cancer Res 2005; 65:10783–10793. 51.Senner V, Sturm A, Baur I, Schrell UH, Distel L, Paulus W. CD24 promotes invasion of glioma cells in vivo. J Neuropathol Exp Neurol 1999; 58:795–802. 52.Huang LR, Hsu HC. Cloning and expression of CD24 gene in human hepatocellular carcinoma: a potential early tumor marker gene correlates with p53 mutation and tumor differentiation. Cancer Res 1995; 55:4717–4721. 53.Sagiv E, Kazanov D, Arber N. CD24 plays an important role in the carcinogenesis process of the pancreas. Biomed Pharmacother 2006; 60:280–284. 54.Sagiv E, Memeo L, Karin A, Kazanov D, Jacob-Hirsch J, Mansukhani M, Rechavi G, Hibshoosh H, Arber N. CD24 is a new oncogene, early at the multistep process of colorectal cancer carcinogenesis. Gastro- enterology 2006; 131:630–639. 55.Kristiansen G, Schluns K, Yongwei Y, Denkert C, Dietel M, Petersen I. CD24 is an independent prognostic marker of survival in non-small cell lung cancer patients. Br J Cancer 2003; 88:231–236. 56.Aigner S, Sthoeger ZM, Fogel M, Weber E, Zarn J, Ruppert M, Zeller Y, Vestweber D, Stahel R, Sammar M, Altevogt P. CD24, a mucin-type glycol- protein, is a ligand for P-selectin on human tumor cells. Blood 1997; 89:3385–3895. 57.Aigner S, Ramos CL, Hafezi-Moghadam A, Lawrence MB, Friederichs J, Altevogt P, Ley K. CD24 mediates rolling of breast carcinoma cells on P-selectin. FASEB J 1998; 12: 1241–1251. 58.Friederichs J, Zeller Y, Hafezi-Moghadam A, Grone HJ, Ley K, Altevogt P. The CD24/P-selectin binding pathway initiates lung arrest of human A125 adenocarcinoma cells. Cancer Res 2000; 60:6714–6722. 59.Kristiansen G, Winzer KJ, Mayordomo E, Bellach J, Schlüns K, Denkert C, Dahl E, Pilarsky C, Altevogt P, Guski H, Dietel M. CD24 expression is a new prognostic marker in breast cancer. Clin Cancer Res 2003; 9: 4906–4913. 60.Kristiansen G, Pilarsky C, Pervan J, Stürzebecher B, Stephan C, Jung K, Loening S, Rosenthal A, Dietel M. CD24 expression is a significant predictor of PSA relapse and poor prognosis in low grade or organ confined prostate cancer. Prostate 2004; 58: 183–92. 61.Zarn JA, Zimmermann SM, Pass MK, Waibel R, Stahel RA. Association of CD24 with the kinase c-fgr in a small cell lung cancer cell line and with the kinase lyn in an erythroleukemia cell line. Biochem Biophys Res Commun 1996; 225:384–391. 62.Welsh JB, Zarrinkar PP, Sapinoso LM, Kern SG, Behling CA, Monk BJ, Lockhart DJ, Burger RA, Hampton GM. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. Proc Natl Acad Sci USA 2001; 98:1176–1181. 63.Senner V, Sturm A, Baur I, Schrell UH, Distel L, Paulus W. CD24 promotes invasion of glioma cells in vivo. J Neuropathol Exp Neurol 1999; 58:795–802. 64.Huang LR, Hsu HC. Cloning and expression of CD24 gene in human hepatocellular carcinoma: a potential early tumor marker gene correlates with p53 mutation and tumor differentiation. Cancer Res 1995; 55:4717–4721. 65.Sagiv E, Kazanov D, Arber N. CD24 plays an important role in the carcinogenesis process of the pancreas. Biomed Pharmacother 2006; 60:280–284. 66.Sagiv E, Memeo L, Karin A, Kazanov D, Jacob-Hirsch J, Mansukhani M, Rechavi G, Hibshoosh H, Arber N.CD24 is a new oncogene, early at the multistep process of colorectal cancer carcinogenesis. Gastro -enterology 2006; 131:630–639. 67.Kristiansen G, Schlüns K, Yongwei Y, Denkert C, Dietel M, Petersen I.CD24 is an independent prognostic marker of survival in non-small cell lung cancer patients. Br J Cancer 2003; 88: 231–236. 68.Choi YL, Kim SH, Shin YK, Hong YC, Lee SJ, Kang SY, Ahn G. Cyto- plasmic CD24 expression in advanced ovarian serous borderline tumors. Gynecol Oncol 2005; 97:379–386. 69.Weichert W, Denkert C, Burkhardt M, Gansukh T, Bellach J, Altevogt P, Dietel M, Kristiansen G. Cytoplasmic CD24 expression in colorectal cancer independently correlates with shortened patient survival. Clin Cancer Res 2005; 11:6574–6581. 70.Chou YY, Jeng YM, Lee TT, Hu FC, Kao HL, Lin WC, Lai PL, Hu RH, Yuan RH. Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma. Ann Surg Oncol 2007; 14: 2748–2758. 71.Yang XR, Xu Y, Yu B, Zhou J, Li JC, Qiu SJ, Shi YH, Wang XY, Dai Z, Shi GM, Wu B, Wu LM, Yang GH, Zhang BH, Qin WX, Fan J. CD24 Is a Novel Predictor for Poor Prognosis of Hepatocellular Carcinoma after Surgery. Clin Cancer Res 2009; 15(17):5518–5527. 72.Sano A, Kato H, Sakurai S, Sakai M, Tanaka N, Inose T, Saito K, Sohda M, Nakajima M, Nakajima T, Kuwano H. CD24 Expression Is a Novel Prognostic Factor in Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2009; 16:506–514. 73.Oikawa T, Yamada T. Molecular biology of the ETS family of trans- cripttion factors. Gene 2003; 303: 11–34. 74.Seth A, Watson DK. ETS transcription factors and their emerging roles in human cancer. Eur J Cancer 2005; 41: 2462–2478. 75.Kas K, Finger E, Grall F, Gu X, Akbarali Y, Boltax J, Weiss A, Oettgen P, Kapeller R, Libermann TA. ESE-3, a novel member of an epithelium- specific ETS transcription factor subfamily, demonstrates different target gene specificity from ESE-1. J Biol Chem 2000; 275: 29 86–2998. 76.Schedin PJ, Eckel-Mahan KL, McDaniel SM, Prescott JD, Brodsky KS, Tentler JJ, Gutierrez-Hartmann A. ESX induces transformation and functional epithelial to mesenchymal transition in MCF-12A mam- mary epithelial cells. Oncogene 2004; 23: 1766–1779. 77.Tugores A, Le J, Sorokina I, Snijders AJ, Duyao M, Reddy PS, Carlee L, Ronshaugen M, Mushegian A, Watanaskul T, Chu S, Buckler A, Emtage S, McCormick MK. The epithelium-specific ETS protein EHF/ESE-3 is a context-dependent transcriptional repressor down- stream of MAPK signaling cascades. J Biol Chem 2001; 276: 203 97–20406. 78.Liu AY, Corey E, Vessella RL, Lange PH, True LD, Huang GM, Nelson PS, Hood L. Identification of differentially expressed prostate genes: increased expression of transcription factor ETS-2 in prostate cancer. Prostate 1997; 30: 145–153. 79.Petrovics G, Liu A, Shaheduzzaman S, Furusato B, Sun C, Chen Y, Nau M, Ravindranath L, Chen Y, Dobi A, Srikantan V, Sesterhenn IA, McLeod DG, Vahey M, Moul JW, Srivastava S. Frequent over- expression of ETS-related gene-1 (ERG1) in prostate cancer transcripttome. Oncogene 2005; 24: 3847–3852. 80.Tomlins SA, Mehra R, Rhodes DR, Smith LR, Roulston D, Helgeson BE, Cao X, Wei JT, Rubin MA, Shah RB, Chinnaiyan AM. TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer. Cancer Res 2006; 66: 3396–3400. 81.Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, Varambally S, Cao X, Tchinda J, Kuefer R, Lee C, Montie JE, Shah RB, Pienta KJ, Rubin MA, Chinnaiyan AM. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 2005; 310: 644–648. 82.Shulewitz M, Soloviev I, Wu T, Koeppen H, Polakis P, Sakanaka C. Repressor roles for TCF-4 and Sfrp1 in Wnt signaling in breast cancer. Oncogene 2006; 25, 4361–4369.
|